Recall
FDAHealthJuly 18, 2024

MAIN PRODUCTS INC — Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

⚠️ Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 18, 2024

Nationwide within the U.S

What's affected?

Product
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Lot code
within

Additional details

All lots within expiry

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 57, 340 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.